首页 正文

Network Medicine-Based Repurposing of Mesalazine for Atherosclerosis Treatment

{{output}}
Atherosclerosis remains a leading cause of cardiovascular disease and mortality worldwide, despite advancements in statin therapies. Here, we aimed to identify potential anti-atherosclerosis drugs by an integrated approach combining network medicine-based pred... ...